Business Wire

Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies and Dutch start-up Cyclomics today announced the ‘developer access’ of a new research workflow: the world’s first nanopore ...
MD&M East

GEDiCube and Cyclomics Join Forces to Further Liquid Biopsy for Cancer Detection

GEDiCube, an advanced artificial intelligence (AI) company wholly owned as a subsidiary of Renovaro, today announced it has executed a binding letter of intent to acquire 75% of Cyclomics, a cancer ...
Business Insider

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing. Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single ...
Pharmabiz

Oxford Nanopore, Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer

Oxford Nanopore Technologies and Dutch start-up Cyclomics announced the ‘developer access’ of a new research workflow: the world’s first nanopore sequencing-based solution for ultra-sensitive ...
Yahoo Finance

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

LOS ANGELES and AMSTERDAM, Feb. 15, 2024 (GLOBE NEWSWIRE) -- GEDiCube (moving forward RenovaroCube), a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc.